scholarly journals Generation of a human iPS cell line (CABi003-A) from a patient with age-related macular degeneration carrying the CFH Y402H polymorphism

2019 ◽  
Vol 38 ◽  
pp. 101473 ◽  
Author(s):  
Ana B. Garcia-Delgado ◽  
Sofia M. Calado ◽  
Lourdes M. Valdes-Sanchez ◽  
Adoracion Montero-Sanchez ◽  
Beatriz Ponte-Zuñiga ◽  
...  
2016 ◽  
Vol 37 (4) ◽  
pp. 459-461 ◽  
Author(s):  
Daniela Prescila Dezidério Sacconi ◽  
José Paulo Cabral de Vasconcellos ◽  
Fábio Endo Hirata ◽  
Flávio MacCord Medina ◽  
Priscila Hae Hyun Rim ◽  
...  

2008 ◽  
Vol 86 (4) ◽  
pp. 390-394 ◽  
Author(s):  
Sanna Seitsonen ◽  
Irma Järvelä ◽  
Seppo Meri ◽  
Petri Tommila ◽  
Päivi Ranta ◽  
...  

2010 ◽  
Vol 88 (5) ◽  
pp. e165-e169 ◽  
Author(s):  
Anderson G. Teixeira ◽  
Aldacilene S. Silva ◽  
Fabio L.H. Lin ◽  
Roberta Velletri ◽  
Lorena Bavia ◽  
...  

2013 ◽  
Vol 49 (4) ◽  
pp. 177-184 ◽  
Author(s):  
I. Habibi ◽  
I. Sfar ◽  
F. Kort ◽  
H. Aounallah-Skhiri ◽  
A. Chebil ◽  
...  

2014 ◽  
Vol 41 (6) ◽  
pp. 386-392 ◽  
Author(s):  
Carlos Eduardo Veloso ◽  
Luciana Negrão Frota de Almeida ◽  
Márcio Bittar Nehemy

Objective: To investigate the association between CFH gene polymorphism and response to ranibizumab in Brazilian patients with neovascular age-related macular degeneration (AMD).Methods: 95 patients were genotyped for the CFH rs1061170 (Y402H) single nucleotide polymorphism. Patients with neovascular AMD initially received intravitreal ranibizumab injections for three months and were retreated as needed. Visual acuity (VA) and central retinal thickness (CRT) were measured before treatment and at 1, 3, 6, and 12 months post-treatment.Results: For patients with the TT and TC genotypes, paired comparisons of VA showed a statistically significant improvement when the data obtained at all visits were compared with baseline. Patients homozygous for the risk genotype (CC) did not show a statistically significant improvement when VA obtained at visits 1, 3, 6 and 12 were compared with baseline. For all genotypes, paired comparisons of CRT showed a statistically significant improvement when the data obtained at visits 1, 3, 6 and 12 were compared with baseline.Conclusion: Patients with the CC genotype showed poorer long-term functional response to intravitreal ranibizumab.


Sign in / Sign up

Export Citation Format

Share Document